Bausch Health Companies Inc. sell marge
Start price
25.11.15
/
50%
€83.57
Target price
24.12.15
€70.00
Performance (%)
26.24%
End price
24.12.15
€105.50
Summary
This prediction ended on 24.12.15 with a price of €105.50. The prediction closed with a disappointing performance of 26.24%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bausch Health Companies Inc. | -0.417% | -0.417% | -31.754% | -41.968% |
| iShares Core DAX® | -0,38 % | 2,61 % | 11,34 % | 61,27 % |
| iShares Nasdaq 100 | -0,41 % | -2,00 % | 5,35 % | 90,63 % |
| iShares Nikkei 225® | 1,84 % | 9,39 % | 33,53 % | 67,98 % |
| iShares S&P 500 | -0,71 % | -0,48 % | 2,51 % | 62,52 % |
Comments by marge for this prediction
In the thread Bausch Health Companies Inc. diskutieren
marge stimmt dem Crowdsentiment von 'Buy' nicht zu
marge stimmt am 25.11.2015 dem Buy-Crowdsentiment mit dem Kursziel 158.45€ überhaupt nicht zu.
Investors believe Valeant's accounting and transparency standards are at
least questionable. Investor confidence, a naturally fragile thing, has
taken such a devastating hit in October and November that a profound
recovery of Valeant Pharmaceuticals' stock price is highly unlikely,
at least in the short-term!
(Vom Mitglied beendet)
Stopped prediction by marge for Bausch Health Companies Inc.
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€16.05
01.01.19
01.01.19
€29.80
04.11.21
04.11.21
45.23%
05.11.21
05.11.21
